Literature DB >> 32816938

Calcitonin negative medullary thyroid cancer in ectopic thyroid tissue: a rare diagnosis in an unusual location.

Gareth Montgomery1, Laurence Collins2, Caroline Coghlin1, Ramzan Ullah1.   

Abstract

Medullary thyroid cancer is an aggressive form of thyroid cancer arising from parafollicular C cells. Calcitonin (CT) is a specific and sensitive biochemical marker which typically aids primary diagnosis and disease surveillance following treatment. There are rare cases of calcitonin negative medullary thyroid cancer (CNMTC) documented in the literature; however, to our knowledge, this case is the first report of CNMTC arising in ectopic thyroid tissue. We report a case of a 45-year-old man who attended his primary care physician with painless anterior neck swelling. In the absence of CT secreting disease, we have demonstrated the investigative process and the importance of immunohistochemical analysis to achieve a diagnosis. We also consider the challenges of monitoring disease recurrence in the absence of reliable biochemical markers. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  ear, nose and throat/otolaryngology; endocrine cancer; head and neck cancer

Mesh:

Substances:

Year:  2020        PMID: 32816938      PMCID: PMC7437975          DOI: 10.1136/bcr-2020-236865

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.

Authors:  Giuseppe Costante; Domenico Meringolo; Cosimo Durante; Davide Bianchi; Maria Nocera; Salvatore Tumino; Umberto Crocetti; Marco Attard; Marianna Maranghi; Massimo Torlontano; Sebastiano Filetti
Journal:  J Clin Endocrinol Metab       Date:  2006-11-21       Impact factor: 5.958

2.  A case of an ectopic thyroid gland at the lateral neck masquerading as a metastatic papillary thyroid carcinoma.

Authors:  Jae-Young Choi; Jeong-Hoon Kim
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

3.  Medullary thyroid carcinoma: The third most common thyroid cancer reviewed.

Authors:  Michael Stamatakos; Panoraia Paraskeva; Charikleia Stefanaki; Paraskevas Katsaronis; Andreas Lazaris; Konstantinos Safioleas; Konstantinos Kontzoglou
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

4.  Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.

Authors:  Kosma Woliński; Jarosław Kaznowski; Aleksandra Klimowicz; Adam Maciejewski; Dagny Łapińska-Cwojdzińska; Edyta Gurgul; Adrian D Car; Marta Fichna; Paweł Gut; Maria Gryczyńska; Marek Ruchała
Journal:  Endokrynol Pol       Date:  2017-06-06       Impact factor: 1.582

5.  Calcitonin-negative neuroendocrine tumor of the thyroid with metastasis to liver-rare presentation of an unusual tumor: A case report and review of literature.

Authors:  Huai-Jie Cai; Han Wang; Nan Cao; Bin Huang; Fan-Lei Kong; Li-Ren Lu; Ya-Yuan Huang; Wei Wang
Journal:  World J Clin Cases       Date:  2020-01-06       Impact factor: 1.337

6.  Serum calcitonin negative medullary thyroid carcinoma.

Authors:  Michael Sand; Marcos Gelos; Daniel Sand; Falk G Bechara; Gerd Bonhag; Ellen Welsing; Benno Mann
Journal:  World J Surg Oncol       Date:  2006-12-21       Impact factor: 2.754

7.  Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.

Authors:  A L Mitchell; A Gandhi; D Scott-Coombes; P Perros
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

Review 8.  Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.

Authors:  Claudio Gambardella; Chiara Offi; Guglielmo Clarizia; Roberto Maria Romano; Immacolata Cozzolino; Marco Montella; Rosa Maria Di Crescenzo; Massimo Mascolo; Angelo Cangiano; Sergio Di Martino; Giancarlo Candela; Giovanni Docimo
Journal:  BMC Endocr Disord       Date:  2019-10-16       Impact factor: 2.763

9.  Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?

Authors:  Claudio Gambardella; Chiara Offi; Renato Patrone; Guglielmo Clarizia; Claudio Mauriello; Ernesto Tartaglia; Francesco Di Capua; Sergio Di Martino; Roberto Maria Romano; Lorenzo Fiore; Alessandra Conzo; Giovanni Conzo; Giovanni Docimo
Journal:  BMC Endocr Disord       Date:  2019-05-29       Impact factor: 2.763

10.  Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules.

Authors:  Luca Giovanella; Mauro Imperiali; Arnoldo Piccardo; Monica Taborelli; Frederik Anton Verburg; Federica Daurizio; Pierpaolo Trimboli
Journal:  Eur J Clin Invest       Date:  2018-04-20       Impact factor: 4.686

View more
  1 in total

1.  Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.

Authors:  Sun Jung Kim; Hyeok Jun Yun; Su-Jin Shin; Yong Sang Lee; Hang-Seok Chang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-05       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.